A common deletion mutation in European patients with Sjögren-Larsson syndrome

Biochem Mol Med. 1997 Dec;62(2):178-81. doi: 10.1006/bmme.1997.2640.

Abstract

Sjögren-Larsson syndrome (SLS) is an inherited neurocutaneous disorder characterized by ichthyosis, mental retardation, spasticity, and deficient activity of fatty aldehyde dehydrogenase (FALDH). We identified a frequent FALDH mutation in exon 9 among SLS probands of European descent. This mutation is a 2-bp deletion of nucleotides GA 1297-1298 and results in premature termination of translation at codon 435 along with substitution of Arg and Cys for Glu433 and Gly434 respectively. The GA del1297-8 mutation was found in 10 of 21 European SLS probands and could be readily detected using an allele-specific PCR method. This GA deletion mutation or a previously identified common point mutation 9C943Y) was present in 66% of the European SLS probands, and the two mutations together accounted for 48% of the SLS alleles. Screening European patients for these two common mutations should be useful for DNA-based diagnosis of SLS and genetic counseling.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aldehyde Oxidoreductases / genetics*
  • Alleles
  • Europe
  • Humans
  • Sequence Deletion / genetics*
  • Sjogren-Larsson Syndrome / enzymology
  • Sjogren-Larsson Syndrome / genetics*

Substances

  • Aldehyde Oxidoreductases
  • long-chain-aldehyde dehydrogenase